SCHEMBL5824741

SCHEMBL5824741

COc1cc2nccc(Oc3ccc(NC(=O)OCCN4CCOCC4)c(C)c3C)c2cc1OC

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FLT3 P36888 5/20 0.58
KDR P35968 4/20 0.54
EGFR P00533 3/20 0.54
AXL P30530 4/20 0.54
MET P08581 10/20 0.54
FGFR2 P21802 2/20 0.54
PLK4 O00444 1/20 0.54
STK25 O00506 1/20 0.54
CIT O14578 1/20 0.54
AURKA O14965 1/20 0.54
CHUK O15111 1/20 0.54
MUSK O15146 1/20 0.54
EPHB6 O15197 1/20 0.54
MAPK13 O15264 1/20 0.54
MAP3K13 O43283 1/20 0.54
DAPK3 O43293 1/20 0.54
MAP3K7 O43318 1/20 0.54
RIPK2 O43353 1/20 0.54
JAK2 O60674 1/20 0.54
ROCK2 O75116 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5825116 0.92 KDR (0.53) KDRAXLMETKITPDGFRA
SCHEMBL5824601 0.88 KDR (0.56) FLT3KDREGFRAXLMET
SCHEMBL5825074 0.88 FLT3 (0.55) FLT3KDREGFRAXLMET
SCHEMBL5825111 0.87 EHMT2 (0.56) MET
SCHEMBL5825821 0.86 FLT3 (0.51) FLT3KDREGFRAXLMET
SCHEMBL5824386 0.85 KDR (0.56) KDREGFRAXLMETFGFR2
SCHEMBL5824752 0.84 MET (0.68) KDREGFRMETFGFR2KIT
SCHEMBL5824454 0.84 FLT3 (0.60) FLT3KDREGFRAXLMET
SCHEMBL5825492 0.83 KDR (0.57) KDREGFRAXLMETFGFR2
SCHEMBL5825310 0.83 AXL (0.54) FLT3KDREGFRAXLMET

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7135466-B2 Quinoline and quinazoline derivatives and drugs containing the same KIRIN BEER KABUSHIKI KAISHA (JP) 2006-11-14 US disclosed
US-20060211717-A1 Quinoline and quinazoline derivatives and drugs containing the same KIRIN BEER KABUSHIKI KAISHA (JP) 2006-09-21 US disclosed
US-20040132727-A1 Quinoline and quinazoline derivatives and drugs containing the same KIRIN HOLDINGS KABUSHIKI KAISHA (JP) 2004-07-08 US disclosed
EP-1243582-A1 QUINOLINE AND QUINAZOLINE DERIVATIVES AND DRUGS CONTAINING THE SAME KIRIN BEER KABUSHIKI KAISHA (JP) 2002-09-25 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060211717-A1 Quinoline and quinazoline derivatives and drugs containing the same PDGFRA, PDGFRB, PDGFA FLT3 68/4885KDR 4/4885EGFR 24/4885
US-20040132727-A1 Quinoline and quinazoline derivatives and drugs containing the same PDGFRA, PDGFRB, PDGFA FLT3 108/4885KDR 5/4885EGFR 20/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.